Suscribirse

Fufang-Zhenzhu-Tiaozhi capsule ameliorates rabbit’s iliac artery restenosis by regulating adiponectin signaling pathway - 18/06/20

Doi : 10.1016/j.biopha.2020.110311 
Tudi Li b, Rendan Zhang b, Yuhong Liu b, Yusi Yao b, Jiao Guo a, , Zhihuan Zeng b,
a Guangdong Pharmaceutical University, China 
b Department of Cardiovascular Diseases, the First Affiliated Hospital of Guangdong Pharmaceutical University, China 

Corresponding author at: 19th, Nong Lin Xia Road, Yue xiu District, Guangzhou, Guangdong Province, China.19th, Nong Lin Xia Road, Yue xiu DistrictGuangzhouGuangdong ProvinceChina⁎⁎Corresponding author at: 280 Outer Ring Road East, University Town, Guangdong Pharmaceutical University, China.University TownGuangdong Pharmaceutical University280 Outer Ring Road EastChina

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

páginas 12
Iconografías 7
Vídeos 0
Otros 0

Graphical abstract




El texto completo de este artículo está disponible en PDF.

Highlights

We find that FTZ up-regulates adiponectin signaling pathway for the first time.
This study explores the potential side effects of FTZ for the first time.
We validated that adiponectin was a new target for the prevention and treatment of vascular restenosis firstly.

El texto completo de este artículo está disponible en PDF.

Abstract

Background and purpose

Fufang-Zhenzhu-Tiaozhi Capsule (FTZ), a traditional Chinese medicine, has been shown obvious effects on the treatment of dyslipidemia and atherosclerosis. The aim of this study was to evaluate whether FTZ can ameliorate rabbit iliac artery restenosis after angioplasty by regulating adiponectin signaling pathway.

Experimental approach

The rabbit iliac artery restenosis model was established through percutaneous iliac artery transluminal balloon angioplasty and a high-fat diet. Twenty eight male New Zealand rabbits (8-week-old) were divided into sham operation group (Group Ⅰ), model group (Group Ⅱ), atorvastatin group (Group Ⅲ) and FTZ group (Group Ⅳ), with 7 rabbits in each group. Vascular stenosis was analyzed with Digital Subtraction Angiography. Level of adiponectin (APN), and inflammatory factor including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) as well as monocyte chemoattractant protein-1 (MCP-1) was measured by Enzyme Linked Immunosorbent Assay; and injured iliac artery was collected for Hematoxylin-eosin staining and Western Blotting detection of expression of peroxisome proliferator-activated receptor-alpha (PPAR-α), adenosine 5′-monophosphate -activated protein kinase (AMPK) and phosphorylated adenosine 5′-monophosphate -activated protein kinase (p-AMPK). Besides, we evaluated FTZ’s safety for the first time.

Key results

Percutaneous iliac artery transluminal balloon angioplasty and high-fat diet result in inflammatory response and restenosis. Compared with Group Ⅱ, iliac artery restenosis was significantly ameliorated in Group Ⅳ (P < 0.05). Treated with FTZ, serum lipids were significantly decreased (P < 0.01), while the level of APN was elevated significantly (P < 0.01). Western blotting detection of the injured iliac artery showed that the expressions of PPAR-α, AMPK and p-AMPK were significantly increased in Group Ⅳ (P < 0.01) than that in Group Ⅱ. Besides, before and after taking drugs, liver and kidney function indicators, creatine kinase, as well as measurement of echocardiography were of no statistical difference in four groups(P > 0.05).

Conclusions and implications

FTZ could effectively reduce serum lipids and ameliorate rabbit’s iliac artery restenosis after angioplasty, and its mechanism may be related to activation of APN signaling pathway.

El texto completo de este artículo está disponible en PDF.

Abbreviations : FTZ, APN, IL-6, TNF-α, MCP-1, PPAR-α, AMPK, p-AMPK

Keywords : FTZ, Adiponectin signal pathway, Lipid, Restenosis after angioplasty


Esquema


© 2020  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 128

Artículo 110311- août 2020 Regresar al número
Artículo precedente Artículo precedente
  • Modulating effect of Coronarin D in 5-fluorouracil resistance human oral cancer cell lines induced apoptosis and cell cycle arrest through JNK1/2 signaling pathway
  • Ming-Yu Hsieh, Ming-Ju Hsieh, Yu-Sheng Lo, Chia-Chieh Lin, Yi-Ching Chuang, Mu-Kuan Chen, Ming-Chih Chou
| Artículo siguiente Artículo siguiente
  • Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction and permeability via the mitogen-activated protein kinase pathway in a rabbit model of atherosclerosis
  • Junli Ding, Zhenzhen Li, Liang Li, Yanhui Ding, Duomei Wang, Song Meng, Qing Zhou, Shuyu Gui, Wei Wei, Huaqing Zhu, Yuan Wang

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.